Fidson Healthcare plc will commission a N7.5 billion drug-making plant this year to offer more options in the Nigerian pharmaceutical industry and grow its portfolio. The new facility will double the company’s production capacity and will, for the first time, add intravenous fluids to Fidson’s
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp